TEVA
Teva Pharma Industries Ltd ADR
NYSE: TEVA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$35.38
+11.89% today
Updated 2026-04-29
Market cap
$41.20B
P/E ratio
26.40
P/S ratio
2.39x
EPS (TTM)
$1.34
Dividend yield
—
52W range
$15 – $37
Volume
6.7M
Teva Pharma Industries Ltd ADR (TEVA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.41B | $9.41B | $11.09B | $13.90B | $16.12B | $18.31B | $20.32B | $20.31B | $20.27B | $19.65B | $21.90B | $22.39B | $18.85B | $16.89B | $16.66B | $15.88B | $14.93B | $15.85B | $16.54B | $17.26B |
| Revenue growth (YoY) | — | +11.9% | +17.8% | +25.4% | +16.0% | +13.6% | +10.9% | -0.0% | -0.2% | -3.1% | +11.5% | +2.2% | -15.8% | -10.4% | -1.4% | -4.7% | -6.0% | +6.2% | +4.4% | +4.3% |
| Cost of revenue | $4.15B | $4.53B | $5.12B | $6.53B | $7.06B | $8.80B | $9.66B | $9.61B | $9.22B | $8.30B | $10.04B | $11.56B | $10.56B | $9.35B | $8.93B | $8.28B | $7.95B | $8.20B | $8.48B | $8.32B |
| Gross profit | $4.26B | $4.88B | $5.97B | $7.37B | $9.06B | $9.52B | $10.65B | $10.71B | $11.06B | $11.36B | $11.86B | $10.82B | $8.30B | $7.54B | $7.73B | $7.59B | $6.97B | $7.64B | $8.06B | $8.94B |
| Gross margin | 50.7% | 51.8% | 53.8% | 53.0% | 56.2% | 52.0% | 52.4% | 52.7% | 54.5% | 57.8% | 54.1% | 48.4% | 44.0% | 44.6% | 46.4% | 47.8% | 46.7% | 48.2% | 48.7% | 51.8% |
| R&D | $495.00M | $581.00M | $786.00M | $802.00M | $933.00M | $1.09B | $1.36B | $1.43B | $1.49B | $1.52B | $2.11B | $1.85B | $1.21B | $1.01B | $1.79B | $1.09B | $838.00M | $953.00M | $1.05B | $1.01B |
| SG&A | $2.07B | $2.48B | $669.00M | $823.00M | $865.00M | $932.00M | $1.24B | $1.24B | $1.22B | $1.24B | $1.24B | $1.33B | $1.30B | $1.19B | $1.17B | $1.10B | $1.18B | $1.16B | $1.16B | $1.29B |
| Operating income | $801.00M | $2.40B | $1.15B | $2.40B | $3.87B | $3.11B | $2.21B | $1.65B | $3.95B | $3.35B | $2.15B | $-17.48B | $-1.64B | $-443.00M | $-3.57B | $1.72B | $-2.20B | $433.00M | $-303.00M | $2.16B |
| Operating margin | 9.5% | 25.5% | 10.3% | 17.3% | 24.0% | 17.0% | 10.9% | 8.1% | 19.5% | 17.1% | 9.8% | -78.1% | -8.7% | -2.6% | -21.4% | 10.8% | -14.7% | 2.7% | -1.8% | 12.5% |
| EBITDA | $2.53B | $2.40B | $1.64B | $2.40B | $4.83B | $4.26B | $3.88B | $3.21B | $5.97B | $6.34B | $2.87B | $-15.52B | $186.00M | $4.44B | $4.61B | $4.41B | $-925.00M | $433.00M | $4.43B | $3.14B |
| EBITDA margin | 30.1% | 25.5% | 14.8% | 17.3% | 29.9% | 23.3% | 19.1% | 15.8% | 29.5% | 32.3% | 13.1% | -69.3% | 1.0% | 26.3% | 27.7% | 27.8% | -6.2% | 2.7% | 26.8% | 18.2% |
| EBIT | $2.10B | $1.87B | $1.15B | $1.50B | $3.85B | $3.19B | $2.17B | $1.56B | $4.47B | $5.03B | $1.37B | $-17.59B | $-1.66B | $2.72B | $3.06B | $3.08B | $-2.23B | $433.00M | $3.37B | $2.14B |
| Interest expense | $2.70B | $112.00M | $318.00M | $230.00M | $225.00M | $153.00M | $355.00M | $282.00M | $276.00M | $465.00M | $1.33B | $895.00M | $881.00M | $957.00M | $755.00M | $891.00M | $930.00M | $1.03B | $941.00M | $916.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $546.00M | $1.95B | $635.00M | $2.00B | $3.33B | $2.76B | $1.96B | $1.27B | $3.06B | $1.59B | $329.00M | $-16.27B | $-2.15B | $-999.00M | $-3.99B | $417.00M | $-2.45B | $-559.00M | $-1.64B | $1.41B |
| Net income growth (YoY) | — | +257.5% | -67.5% | +215.0% | +66.5% | -17.2% | -28.9% | -35.4% | +140.7% | -48.0% | -79.3% | -5043.8% | +86.8% | +53.5% | -299.4% | +110.5% | -686.6% | +77.1% | -193.2% | +186.0% |
| Profit margin | 6.5% | 20.7% | 5.7% | 14.4% | 20.7% | 15.1% | 9.7% | 6.2% | 15.1% | 8.1% | 1.5% | -72.7% | -11.4% | -5.9% | -24.0% | 2.6% | -16.4% | -3.5% | -9.9% | 8.2% |